Ancilia

Developer of microbiome therapies for immunology and oncology indications

placeNew York City, New York, United States calendar_todayFounded 2019 groups5 employees language anciliabio.com

Social engagement

Social engagement: 3.6K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Safar Partners.

Investor typeCountShare
Venture capital563%
Other / undisclosed338%

Recent activity

14 May 2026
Leadership hire
Head of CMC
Coming soon